Table 3.
Changes in annual DDD and drug expenditures (year-to-year rates of increase in parenthesis)
| 2005 | 2006 | 2007 | 2008 | 2009 | 2005-2009 | Annual | ||
|---|---|---|---|---|---|---|---|---|
| Statin |
Sum of DDD |
128,545,620 |
193,278,414 (50.36%) |
274,288,699 (41.91%) |
344,893,058 (25.74%) |
445,426,185 |
246.51% |
36.44% |
| Drug expenditure per DDD (unit: won) |
1,506 |
1,392 |
1,276 |
1,185 |
1,085 |
−27.95% |
−7.87% |
|
| Total statin expenditure (unit: million won) |
193.6 |
269.0 (38.96%) |
350.0 (30.12%) |
408.8 (16.82%) |
483.1 (18.16%) |
149.57% |
25.69% |
|
| All Lipid-lowering drugs |
Sum of DDD |
154,832,421 |
224,516,146 (45.01%) |
314,095,889 (39.90%) |
392,818,319 (25.06%) |
506,311,055 (28.89%) |
227.01% |
34.47% |
| Drug expenditure per DDD (unit: won) |
1,349 |
1,285 |
1,206 |
1,136 |
1,052 |
−22.02% |
−6.03% |
|
| Total expenditure (unit: million won) | 208.9 | 288.5 (38.09%) | 378.7 (31.27%) | 446.1 (17.82%) | 532.5 (19.36%) | 154.93% | 26.36% | |
* The drug expenditure was adjusted for inflation.